These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 1664242)
41. Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature. Peters M; Timm U; Schürmann D; Pohle HD; Ruf B Clin Investig; 1992 May; 70(5):456-8. PubMed ID: 1318131 [TBL] [Abstract][Full Text] [Related]
45. [Prevention of genital erosions during treatments with foscarnet of cytomegalovirus infections in AIDS]. Lowenstein W; Fadlallah JP; Roudière L; Deneux C; Haas C; Durand H Presse Med; 1991 Nov; 20(39):1951. PubMed ID: 1662375 [No Abstract] [Full Text] [Related]
46. Foscarnet sodium. Minor JR; Baltz JK DICP; 1991 Jan; 25(1):41-7. PubMed ID: 1848959 [TBL] [Abstract][Full Text] [Related]
47. Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG). Control Clin Trials; 1992 Feb; 13(1):22-39. PubMed ID: 1315661 [TBL] [Abstract][Full Text] [Related]
48. Design of a randomized controlled trial of foscarnet in patients with cytomegalovirus retinitis associated with acquired immunodeficiency syndrome. Polis MA Am J Med; 1992 Feb; 92(2A):22S-25S. PubMed ID: 1310572 [TBL] [Abstract][Full Text] [Related]
49. Foscarnet infusion at home. Wood G; Whitby M; Hogan P; Frazer I Lancet; 1989 Jan; 1(8630):156. PubMed ID: 2563066 [No Abstract] [Full Text] [Related]
50. [Cytomegalovirus ileocolitis in patients with HIV infection is a treatable cause of severe abdominal problems]. Söderlund C; Bratt G; Grützmeier S; Rieger A; Sandström E; Sjunnesson M Lakartidningen; 1991 Dec; 88(49):4249-50. PubMed ID: 1721990 [No Abstract] [Full Text] [Related]
52. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. MacGregor RR; Graziani AL; Weiss R; Grunwald JE; Gambertoglio JG J Infect Dis; 1991 Oct; 164(4):785-7. PubMed ID: 1654363 [TBL] [Abstract][Full Text] [Related]
53. Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS. Farthing C; Anderson MG; Ellis ME; Gazzard BG; Chanas AC J Med Virol; 1987 Jun; 22(2):157-62. PubMed ID: 3039052 [TBL] [Abstract][Full Text] [Related]
54. Fixed drug eruption due to foscarnet. Connolly GM; Gazzard BG; Hawkins DA Genitourin Med; 1990 Apr; 66(2):97-8. PubMed ID: 2160425 [TBL] [Abstract][Full Text] [Related]
55. Characteristics of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Heinemann MH Am J Med; 1992 Feb; 92(2A):12S-16S. PubMed ID: 1310570 [TBL] [Abstract][Full Text] [Related]
56. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Chrisp P; Clissold SP Drugs; 1991 Jan; 41(1):104-29. PubMed ID: 1706982 [TBL] [Abstract][Full Text] [Related]
57. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis. Farese RV; Schambelan M; Hollander H; Stringari S; Jacobson MA Ann Intern Med; 1990 Jun; 112(12):955-6. PubMed ID: 2160217 [No Abstract] [Full Text] [Related]